Personalized Immunosuppression In Transplantation: Role Of Biomarker Monitoring And Therapeutic…

Paperback | September 3, 2015

byMichael OellerichEditorAmitava Dasgupta

not yet rated|write a review
Personalized Immunosuppression in Transplantation: Role of Biomarker Monitoring and Therapeutic Drug Monitoring provides coverage of the various approaches to monitoring immunosuppressants in transplant patients, including the most recently developed biomarker monitoring methods, pharmacogenomics approaches, and traditional therapeutic drug monitoring. The book is written for pathologists, toxicologists, and transplant surgeons who are involved in the management of transplant patients, offering them in-depth coverage of the management of immunosuppressant therapy in transplant patients with the goal of maximum benefit from drug therapy and minimal risk of drug toxicity. This book also provides practical guidelines for managing immunosuppressant therapy, including the therapeutic ranges of various immunosuppressants, the pitfalls of methodologies used for determination of these immunosuppressants in whole blood or plasma, appropriate pharmacogenomics testing for organ transplant recipients, and when biomarker monitoring could be helpful. Focuses on the personalized management of immunosuppression therapy in individual transplant patients Presents information that applies to many areas, including gmass spectrometry, assay design, assay validation, clinical chemistry, and clinical pathology Provides practical guidelines for the initial selection and subsequent modifications of immunosuppression therapy in individual transplant patients Reviews the latest research in biomarker monitoring in personalizing immunosuppressant therapy, including potential new markers not currently used, but with great potential for future use Explains how monitoring graft-derived, circulating, cell free DNA has shown promise in the early detection of transplant injury in liquid biopsy

Pricing and Purchase Info

$126.32 online
$137.95 list price (save 8%)
In stock online
Ships free on orders over $25

From the Publisher

Personalized Immunosuppression in Transplantation: Role of Biomarker Monitoring and Therapeutic Drug Monitoring provides coverage of the various approaches to monitoring immunosuppressants in transplant patients, including the most recently developed biomarker monitoring methods, pharmacogenomics approaches, and traditional therapeutic...

Michael Oellerich, MD, HonMD, FACB, FAMM, FFPath (RCPI), FRCPath, is a chemical pathologist. Since 2012, he has had an appointment as a Lower Saxony Distinguished Professor of Clinical Chemistry at the Department of Clinical Pharmacology, Medical Faculty (UMG) of the George-August University, Göttingen, Germany. He was Chairman of the ...
Format:PaperbackDimensions:316 pages, 8.75 × 6.35 × 0.68 inPublished:September 3, 2015Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0128008857

ISBN - 13:9780128008850

Look for similar items by category:

Customer Reviews of Personalized Immunosuppression In Transplantation: Role Of Biomarker Monitoring And Therapeutic Drug Monitoring

Reviews

Extra Content

Table of Contents

Chapter 1. Overview of the pharmacology and toxicology of immunosuppressant agents that require therapeutic drug monitoring

Chapter 2. Limitations of Immunoassays Used for Therapeutic Drug Monitoring of Immunosuppressants

Chapter 3. Application of liquid chromatography combined with mass spectrometry or tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants

Chapter 4. Monitoring Free Mycophenolic Acid Concentration: Is There any Clinical Advantage?

Chapter 5. Pharmacogenomics aspect of immunosuppressant therapy

Chapter 6. Biomarker monitoring in immunosuppressant therapy: An overview

Chapter 7. Graft-derived cell-free DNA as a Marker of Graft Integrity after Transplantation

Chapter 8. Biomarkers of tolerance in kidney transplantation

Chapter 9. Intracellular concentrations of immunosuppressants

Chapter 10. Markers of lymphocyte activation and proliferation

Chapter 11. Monitoring Calcineurin inhibitors response based on NFAT-regulated gene expression